Eiger BioPharmaceuticals OverviewEiger BioPharmaceuticals Research & Development
Research & Development expenses for EIGR.
Quarterly R&D Expenses
$11.61M
↓ 37.29% YoY
As of Dec 31, 2023
Annual R&D Expenses (TTM)
$62.33M
↓ 17.2% YoY
Trailing 12 months ending Dec 31, 2023